Global Lipid Nanoparticles (LNP) Market Growth (Status and Outlook) 2025-2031

The global Lipid Nanoparticles (LNP) market size is predicted to grow from US$ 493 million in 2025 to US$ 764 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.

LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.

The world"s core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world"s largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.

LPI (LP Information)' newest research report, the “Lipid Nanoparticles (LNP) Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticles (LNP) sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticles (LNP) sales for 2025 through 2031. With Lipid Nanoparticles (LNP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticles (LNP) industry.

This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticles (LNP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Nanoparticles (LNP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticles (LNP) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticles (LNP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticles (LNP).

This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticles (LNP) market by product type, application, key players and key regions and countries.

Segmentation by Type:

mRNA-lipid Nanoparticle

siRNA-lipid Nanoparticle

Others

Segmentation by Application:

Vaccines and Drugs

Scientific Research

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Precision NanoSystems

Evonik

Merck KGaA

Genevant Sciences

Exelead

Avanti Polar Lipids

Nippon Fine Chemical

Lipoid

Please note: The report will take approximately 2 business days to prepare and deliver.